Literature DB >> 16099909

Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets.

Eriko Yamada1, Maria Montoya1, Christian G Schuettler2, Timothy P Hickling3, Alexander W Tarr3, Alessandra Vitelli4, Jean Dubuisson5, Arvind H Patel6, Jonathan K Ball3, Persephone Borrow1.   

Abstract

Hepatitis C virus (HCV) binding to hepatocytes is thought to be mediated via interaction of the E2 glycoprotein with (co-)receptors including CD81 and scavenger receptor class B type I (SR-BI). Here, the expression of CD81 and SR-BI was analysed on peripheral blood mononuclear cell (PBMC) subsets, and the binding of genotype 1 soluble truncated E2 (sE2) proteins to these cells was investigated. All PBMC subsets expressed CD81, although at varying levels. In contrast, SR-BI was only detected on monocytes and dendritic cells (DCs). The genotype 1a H77c sE2 protein showed higher PBMC binding than other genotype 1a/b sE2s. H77c sE2 binding to different PBMC subsets largely paralleled their level of CD81 expression, and could be inhibited by blocking E2-CD81 interaction. However, those PBMC subsets reported to be infected by HCV in vivo (monocytes, DCs and B cells) also exhibited residual, CD81-independent binding, indicating roles for SR-BI/other receptor(s) in mediating haematopoietic cell infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099909     DOI: 10.1099/vir.0.81169-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells.

Authors:  Heidi Barth; Eva K Schnober; Christoph Neumann-Haefelin; Christine Thumann; Mirjam B Zeisel; Helmut M Diepolder; Zongyi Hu; T Jake Liang; Hubert E Blum; Robert Thimme; Mélanie Lambotin; Thomas F Baumert
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

2.  Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry.

Authors:  Kristelle S Brown; Michael J Keogh; Ania M Owsianka; Richard Adair; Arvind H Patel; James N Arnold; Jonathan K Ball; Robert B Sim; Alexander W Tarr; Timothy P Hickling
Journal:  Protein Cell       Date:  2010-07-29       Impact factor: 14.870

3.  Recombinant human L-ficolin directly neutralizes hepatitis C virus entry.

Authors:  Mohamed R Hamed; Richard J P Brown; Carsten Zothner; Richard A Urbanowicz; Christopher P Mason; Anders Krarup; C Patrick McClure; William L Irving; Jonathan K Ball; Mark Harris; Timothy P Hickling; Alexander W Tarr
Journal:  J Innate Immun       Date:  2014-05-15       Impact factor: 7.349

4.  Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.

Authors:  Mohammed A Sarhan; Annie Y Chen; Tomasz I Michalak
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 5.  Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence.

Authors:  Dennis Revie; Syed Zaki Salahuddin
Journal:  Virol J       Date:  2011-07-11       Impact factor: 4.099

Review 6.  The role of humoral innate immunity in hepatitis C virus infection.

Authors:  Alexander W Tarr; Richard A Urbanowicz; Jonathan K Ball
Journal:  Viruses       Date:  2012-01-05       Impact factor: 5.048

Review 7.  Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy.

Authors:  Mirjam B Zeisel; Heidi Barth; Catherine Schuster; Thomas F Baumert
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

Review 8.  Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles.

Authors:  Hong Kiat Lim; Gary P Jeffrey; Grant A Ramm; Carolina Soekmadji
Journal:  Front Cell Infect Microbiol       Date:  2020-11-10       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.